CompletedNCT01849692
ESBA1008 Microvolume Study
PHASE2 · 107 planned enrolment
- Countries listed
- 0
- Registry update
- March 24, 2016
immortal.lifeTrial registrations containing the exact intervention label ESBA1008 solution.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 107 planned enrolment
PHASE2 · 173 planned enrolment
PHASE1 · PHASE2 · 376 planned enrolment